So there’s bad news, more bad news, and even more bad news, and good news. Then there’s bad news and good news.  Which do you want first?

Ah, yes.  Understood.  Let’s get most of the bad out of the way first to get on to sunnier days.

The first bit of the bad is that those long lines that you’re standing in to get tested for Covid -19’s latest variant Omicron aren’t going to get shorter anytime soon.  New cases have exploded to surpass the previous highs of the late Spring of 2020.

And when you finally get to the front of the line and assuming they haven’t run out of test kits, the results might not be accurate so says the FDA.  “Covid-19 antigen tests may be less capable of detecting the fast-spreading Omicron variant,” the Food and Drug Administration cautioned on Tuesday.

If you test negative but exhibit the symptoms, stay home they ask.  Sure.

The new warning is based on preliminary studies by the National Institutes of Health’s Rapid Acceleration of Diagnostics initiative using patient samples with the live virus — analysis that “represents the best way to evaluate true test performance in the short-term,” according to FDA.

The good news is that help is on the way.  The Biden administration has signed a $137 million contract with a pharmaceutical company for the purpose of building a factory for COVID-19 test strip materials, a White House official confirmed yesterday.

But it’s going to take a while.  The new facility will not start churning out the materials for three years, according to the company.  Never mind that the administration is under fire for reportedly rejecting a deal in October that would have strongly ramped up the supply of COVID tests available now.  Remember, Biden always says, get vaccinated, NOW!  Maybe his new command will be, “Get tested, LATER!”

Of course, the bad news is that the three-year timeline also signals that the administration expects the need for tens of millions of such tests per month into 2024 or 2025 and beyond.

So, Covid-19 has plans to have a sixth and seventh sequel called Covid-24 and Covid-25?  How many Friday the Thirteenth’s can you watch?

At least $137 million is cheap money for such non-entertainment in these inflationary times.

Further, the multi-department cooperation by our government is heartening.  The Department of Defense issued a press release stating that it had awarded the contract in coordination with the Department of Health and Human Services.  It was funded through the American Rescue Plan Act.

Got that?  Government red tape never has supply chain issues.

The White House inked the agreement with MilliporeSigma, a subsidiary of German firm Merck KGaA, not to be confused with U.S. company Merck & Co.

“The money will allow the company over three years to build a new facility to produce nitrocellulose membranes, the paper that displays test results, in Sheboygan, Wisconsin,” the outlet reported. “That, in turn, will allow for 85 million more tests to be produced per month.”

Well, at least that’s some good economic news for Wisconsin.  After the Kenosha riots that never should have happened, the subsequent trial that never should have happened, and the SUV in Waukesha that ran down its citizens at a parade, they could use a dose of good news.

And, based on the above we could use another dose or two from Pfizer to boost our spirits as well.